STOCK TITAN
  1. Home
  2. Sec-filings
  3. ZTS
  4. [Form 4] Zoetis Inc. Insider Trading Activity

Zoetis (ZTS) EVP Roxanne Lagano receives 550 phantom stock units

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Lagano Roxanne reported acquisition or exercise transactions in this Form 4 filing.

Zoetis Inc. Executive Vice President Roxanne Lagano received a grant of 550.6436 phantom stock units under the Zoetis Supplemental Savings Plan. Each unit’s value is tied to Zoetis common stock plus a small cash-equivalent component, and the award is settled in cash after her separation from service.

The grant corresponds to 185.1986 shares of underlying Zoetis common stock for value-tracking purposes, and brings her total phantom stock unit balance to 30,632.2157 units. The units may be transferred into alternative investment funds, although Zoetis may limit the timing and frequency of such transfers.

Positive

  • None.

Negative

  • None.
Insider Lagano Roxanne
Role Executive Vice President
Type Security Shares Price Value
Grant/Award Phantom Stock Unit 550.6436 $39.64 $22K
Holdings After Transaction: Phantom Stock Unit — 30,632.2157 shares (Direct)
Footnotes (2)
  1. F1. These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.
  2. F2. Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.
Phantom stock units granted 550.6436 units Grant under Zoetis Supplemental Savings Plan on April 10, 2026
Reference price per unit $39.6400 Transaction price per phantom stock unit
Total phantom units after grant 30,632.2157 units Phantom stock unit balance following the transaction
Underlying common stock 185.1986 shares Underlying Zoetis common stock amount linked to the grant
Cash-equivalent component around 5% Typical share of each phantom stock unit’s total value
Phantom Stock Unit financial
"These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash..."
Zoetis Supplemental Savings Plan financial
"These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash..."
cash-equivalent investments financial
"plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value..."
phantom share financial
"Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock..."

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →

FAQ

What did Zoetis (ZTS) executive Roxanne Lagano report in this Form 4?
Roxanne Lagano reported receiving a grant of 550.6436 phantom stock units under the Zoetis Supplemental Savings Plan. These units track the value of Zoetis common stock and increase her total phantom stock unit holdings to 30,632.2157 units after the transaction.

How many Zoetis phantom stock units were granted to Roxanne Lagano?
She was granted 550.6436 phantom stock units. This award is recorded as a derivative acquisition and is designed to mirror the value of Zoetis common stock, with an additional small cash-equivalent component embedded in each unit’s value calculation.

How are Roxanne Lagano’s Zoetis phantom stock units valued?
Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock plus cash-equivalent investments. The filing notes the cash-equivalent investments typically represent around 5% of total unit value, with overall value determined by Zoetis’ market price and those cash-equivalents.

When will Roxanne Lagano’s Zoetis phantom stock units be settled?
The phantom stock units are settled in cash following her separation from service. Until then, she may transfer them into alternative investment funds, subject to Zoetis’ ability to limit the timing, frequency and permissibility of such transfers under the plan rules.

Does this Zoetis Form 4 show an open-market buy or sell of ZTS shares?
No, the Form 4 shows a grant of phantom stock units classified as a derivative acquisition. It is compensation-related rather than an open-market purchase or sale, with value tied to Zoetis common stock and paid out in cash after separation from service.

What is the underlying Zoetis common stock amount for this phantom unit grant?
The filing states the 550.6436 phantom stock units correspond to 185.1986 underlying shares of Zoetis common stock for value-tracking purposes. This linkage helps determine how the phantom units’ value moves with the market price of Zoetis shares over time.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Lagano Roxanne
(Last)(First)(Middle)
C/O ZOETIS INC.
10 SYLVAN WAY
(Street)
PARSIPPANY NEW JERSEY 07054
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Zoetis Inc. [ ZTS ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Executive Vice President
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/10/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Phantom Stock Unit(1)(2)04/10/2026A550.6436 (1) (1)Common Stock185.1986$39.6430,632.2157D
Explanation of Responses:
1. These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.
2. Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.
Remarks:
/s/ Brenda Santuccio, as Attorney-in-Fact04/13/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR